The shift in the interaction dynamics of HER2 due to HER2 DDMs was also validated by performing co-IP and western blot analysis in the BT-474 cell line (another HER2-high BC cell line), (Supplementary Fig. S3A). Here, ERBB2 is linked to breast cancer.